(Q46860864)

25 December 2017

title

Asymmetric dimethylarginine and impaired cardiovascular healing (English)

1 reference

25 December 2017

author name string

Giulio Coluzzi

1

1 reference

25 December 2017

Eleonora Santucci

2

1 reference

25 December 2017

Francesca Marzo

3

1 reference

25 December 2017

Felicita Andreotti

4

1 reference

25 December 2017

publication date

10 December 2007

1 reference

25 December 2017

Journal of Thrombosis and Thrombolysis

published in

1 reference

25 December 2017

volume

27

1 reference

25 December 2017

issue

2

1 reference

25 December 2017

page(s)

168-171

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1007/s11239-007-0181-y

exact match

0 references

cites work

Contrast-induced nephropathy and mortality: possible crucial role of asymmetric dimethylarginine

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11239-007-0181-Y

Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11239-007-0181-Y

Abnormal asymmetric dimethylarginine/nitric oxide balance in patients with documented coronary artery disease: relation to renal function and homocysteine

21 January 2018

1 reference

12 December 2020

Role of asymmetric dimethylarginine in homocysteine-induced apoptosis of vascular smooth muscle cells

1 reference

12 December 2020

Uncomplicated type 1 diabetes is associated with increased asymmetric dimethylarginine concentrations.

1 reference

12 December 2020

Asymmetrical dimethylarginine in renal disease: limits of variation or variation limits? A systematic review

1 reference

12 December 2020

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

1 reference

12 December 2020

ADMA: a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease

1 reference

12 December 2020

Circulating endothelial progenitor cells and cardiovascular outcomes

1 reference

12 December 2020

Dimethylarginine dimethylaminohydrolase promotes endothelial repair after vascular injury

1 reference

12 December 2020

Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans

1 reference

12 December 2020

Mobilizing endothelial progenitor cells

1 reference

12 December 2020

Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease

1 reference

12 December 2020

Circulating endothelial progenitor cells, vascular function, and cardiovascular risk

1 reference

12 December 2020

Atherothrombotic disorders: new insights from hematology

1 reference

12 December 2020

Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine

1 reference

12 December 2020

The ADMA/DDAH pathway is a critical regulator of endothelial cell motility

1 reference

12 December 2020

Liquid chromatography-tandem mass spectrometry method for the analysis of asymmetric dimethylarginine in human plasma

1 reference

12 December 2020

Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure

1 reference

12 December 2020

5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling

1 reference

12 December 2020

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

1 reference

12 December 2020

Asymmetric dimethylarginine induces apoptosis via p38 MAPK/caspase-3-dependent signaling pathway in endothelial cells

1 reference

12 December 2020

10.1007/S11239-007-0181-Y

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017